Comparative varicella vaccine effectiveness during outbreaks in day-care centres.
about
[The epidemiology of varicella disease in Germany after introduction of a vaccination recommendation : Analysis of mandatory and sentinel data between 2002 and 2014].Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015Primary versus secondary failure after varicella vaccination: implications for interval between 2 dosesDeterminants of varicella breakthrough: results of a 2012 case control study.Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.Vaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMVOne-dose vaccination associated with attenuated disease severity of adolescent and adult varicella cases in Beijing's Fengtai District.Deep Sequencing of Distinct Preparations of the Live Attenuated Varicella-Zoster Virus Vaccine Reveals a Conserved Core of Attenuating Single-Nucleotide Polymorphisms.Issues in pediatric vaccine-preventable diseases in low- to middle-income countriesMolecular studies of the Oka varicella vaccine.Clinical and molecular aspects of the live attenuated Oka varicella vaccine.Varicella vaccination - the global experience.Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions.Population diversity in batches of the varicella Oka vaccineAssessment of varicella vaccine effectiveness in Germany: a time-series approach.An evaluation of voluntary 2-dose varicella vaccination coverage in New York City public schools.
P2860
Q31144265-08A60F68-131B-4D29-A7C3-E833F3115704Q33698107-84FF5A7C-41C6-408C-9432-CD3FBB755497Q33880341-37105DA0-33F5-4A6B-B600-F89590975212Q34033922-70D0D92E-580F-4507-9C38-5576B217D8E5Q34991446-3155F2A9-0F41-4D06-ABAA-6F627A8A0368Q36887989-37548770-A968-4CE4-9DC7-71B1A52B291BQ36978442-25BB855D-D13C-4691-BEC5-389897753F7EQ37252950-BC5294F7-7E25-41C6-BBEF-5533AEDB4420Q37264972-50D4F828-16AA-4647-9069-E88188350A27Q37932527-CBB305ED-EACD-42BA-8915-1F8875B2DA04Q38200971-3182FBFA-0C29-46CE-B6E9-94F7D5F539D9Q39394364-C6E7E57D-4C40-4B72-B2F6-95C097E1FCF3Q41857926-6E06C2DA-BEB2-4106-96F3-CD22179F8840Q42292725-6D2E2B82-7DE5-42AF-878C-CA0058C19DDFQ51612404-8CD5B0D5-9F40-4FE7-B098-E927B6CB1FD0Q51673879-ED4D21F9-EA6C-4039-8C25-535E30EA0C66
P2860
Comparative varicella vaccine effectiveness during outbreaks in day-care centres.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Comparative varicella vaccine effectiveness during outbreaks in day-care centres.
@en
Comparative varicella vaccine effectiveness during outbreaks in day-care centres.
@nl
type
label
Comparative varicella vaccine effectiveness during outbreaks in day-care centres.
@en
Comparative varicella vaccine effectiveness during outbreaks in day-care centres.
@nl
prefLabel
Comparative varicella vaccine effectiveness during outbreaks in day-care centres.
@en
Comparative varicella vaccine effectiveness during outbreaks in day-care centres.
@nl
P2093
P1433
P1476
Comparative varicella vaccine effectiveness during outbreaks in day-care centres.
@en
P2093
D Matysiak-Klose
M Wiese-Posselt
U Heininger
P304
P356
10.1016/J.VACCINE.2009.10.086
P407
P577
2009-10-27T00:00:00Z